Geron Corp. (NASDAQ: GERN) is 102.84% higher on its value in year-to-date trading and has touched a low of $1.64 and a high of $5.34 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GERN stock was last observed hovering at around $4.29 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $4.28, the stock is -5.86% and -6.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.44 million and changing -0.23% at the moment leaves the stock 30.84% off its SMA200. GERN registered 72.58% gain for a year compared to 6-month gain of 104.78%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.96% loss in the last 1 month and extending the period to 3 months gives it a 7.00%, and is -5.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.51% over the week and 4.84% over the month.
Geron Corp. (GERN) has around 141 employees, a market worth around $2.58B and $1.37M in sales. Profit margin for the company is -15990.68%. Distance from 52-week low is 160.98% and -19.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.48%).
Geron Corp. quarterly earnings per share for the current quarter are estimated at -0.09 with sales reaching $16.32M over the same period.The EPS is expected to shrink by -9.51% this year, but quarterly earnings will post 21,853.60% year-over-year. Quarterly sales are estimated to grow 9,851.20% in year-over-year returns.
316.0 institutions hold shares in Geron Corp. (GERN), with institutional investors hold 78.14% of the company’s shares. The shares outstanding are 602.80M, and float is at 551.80M with Short Float at 12.52%. Institutions hold 78.07% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 46.55 million shares valued at $197.38 million. The investor’s holdings represent 7.7138 of the GERN Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 46.2 million shares valued at $195.9 million to account for 7.6558 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 31.93 million shares representing 5.2914 and valued at over $135.4 million, while VIVO CAPITAL, LLC holds 4.5113 of the shares totaling 27.23 million with a market value of $115.44 million.
Geron Corp. (GERN) Insider Activity
The most recent transaction is an insider sale by GRETHLEIN ANDREW J, the company’s EVP, Chief Operating Officer. SEC filings show that GRETHLEIN ANDREW J sold 674,348 shares of the company’s common stock on Jul 08 ’24 at a price of $4.56 per share for a total of $3.07 million. Following the sale, the insider now owns 0.0 shares.
Geron Corp. disclosed in a document filed with the SEC on Jun 10 ’24 that Feller Faye (EVP, Chief Medical Officer) sold a total of 287,900 shares of the company’s common stock. The trade occurred on Jun 10 ’24 and was made at $4.63 per share for $1.33 million. Following the transaction, the insider now directly holds 0.0 shares of the GERN stock.
Still, SEC filings show that on Jun 10 ’24, Kapur Anil (EVP, Corp Strategy & CCO) disposed off 421,875 shares at an average price of $4.64 for $1.96 million. The insider now directly holds 0 shares of Geron Corp. (GERN).
